tm logo
AVANAGE
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 02 Jun 2008

Last Applicant/ Owned by

c/o FGR Corp Svcs, 254 Munoz Rivera Ave

254 Munoz Rivera Ave.

PR

00918

Serial Number

78527718 filed on 06th Dec 2004

Registration Number

N/A

Correspondent Address

Maribeth Day Case

GlaxoSmithKline

CIP Trademarks; UW2220

709 Swedeland Road

King of Prussia PA 19406

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

AVANAGE

pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiopulmonary, genitourinary, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations

Classification Information


Class [005]
Pharmaceutical Products


pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiopulmonary, genitourinary, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations

Mark Details


Serial Number

No 78527718

Mark Type

No Service/Collective Mark

Attorney Docket Number

No App / AVANAG

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
06th Aug 2008ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
06th Aug 2008ABANDONMENT - NO USE STATEMENT FILED
17th Oct 2007EXTENSION 3 GRANTED
09th Oct 2007TEAS EXTENSION RECEIVED
09th Oct 2007EXTENSION 3 FILED
24th May 2007EXTENSION 2 GRANTED
24th May 2007TEAS EXTENSION RECEIVED
24th May 2007EXTENSION 2 FILED
30th Nov 2006EXTENSION 1 FILED
30th Nov 2006TEAS EXTENSION RECEIVED